Browse By

Daily Archives: March 21, 2024

Benevolent AI CEO discusses 2023 highlights and 2024 outlook as it pioneers AI in drug discovery

–News Direct– BenevolentAI (OTC:BAIVF) CEO Dr Joerg Moeller outlines the company's operational and corporate milestones for 2023, categorising achievements into five key areas: clinic operations, proprietary pipeline progress, platform enhancement, organisational growth, and financial management. Moeller noted that BAI secured a significant deal with Merck

NetScientific: Significant Advancement with Strategic Goals

–News Direct– NetScientific PLC (AIM:NSCI) CEO Dr Ilian Iliev discusses the substantial progress made in achieving its strategic objectives for 2023, despite facing challenging market conditions. Iliev told Proactive's Stephen Gunnion the company, a listed deep tech investor, has capitalized on the growing interest in